Wayne D Inman

Title: Wayne D. Inman: Innovator in Diabetes Treatment

Introduction

Wayne D. Inman is a notable inventor based in Belmont, California, recognized for his contributions to the field of diabetes treatment. With a total of three patents to his name, Inman's work focuses on innovative methods for managing blood glucose levels.

Latest Patents

Inman's latest patents include a method of reducing blood glucose by administering Harunganin or Vismin. This patent describes the use of extracts from Harungana or Vismia species, or anthracenone compounds harunganin and vismin, as hypoglycemic agents. These extracts are particularly derived from H. madagascariensis and are beneficial for treating both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes. Another significant patent involves novel hypoglycemically active eremophilanolide sesquiterpenes isolated from Psacalium species. This patent outlines processes for obtaining these compounds and their application as hypoglycemic agents, especially in diabetes treatment.

Career Highlights

Wayne D. Inman is associated with Shaman Pharmaceuticals, Inc., where he has made significant strides in pharmaceutical innovations. His research and development efforts have led to advancements in the treatment of diabetes, showcasing his commitment to improving patient outcomes.

Collaborations

Inman has collaborated with notable colleagues, including Jian Luo and Michael John Reed. These partnerships have contributed to the successful development of his patented technologies and have enhanced the impact of his work in the medical field.

Conclusion

Wayne D. Inman stands out as an influential inventor in the realm of diabetes treatment, with a focus on innovative methods to manage blood glucose levels. His contributions through patents and collaborations reflect his dedication to advancing healthcare solutions.